Invesaro

Stocks RMHI Financial statements

Financial statements

Retrieve Medical Holdings, Inc. financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data Retrieve Medical Holdings, Inc. files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

FY2013FY2014FY2015FY2016FY2017FY2018FY2019FY2020FY2021FY2022
Research and development0.030.01
Selling, general and administrative0.020.02
Selling and marketing-0.04
General and administrative0.012.670.460.190.040.030.010.010.070.16
Operating expenses0.013.092.34-1.090.040.030.010.010.070.16
Operating income-2.341.09-0.04-0.03-0.01-0.01-0.07-0.16
Interest expense-0.70000.010.010.010.010.03
Pre-tax income-0.01
Income tax00
Income from continuing operations-0.01-3.09-2.341.09-0.05
Net income to minority interests-0.01
Net income-0.01-3.76-2.311.16-0.05-0.03-0.01-0.02-0.08-0.16
EBITDA-2.331.11
EPS, basic0.000.000.000.000.000.00
EPS, diluted0.000.000.000.000.000.00
Shares, basic (weighted)22175.278.378.478.478.478.478.478.4
Shares, diluted (weighted)33175.278.380.978.478.478.478.478.4

Balance sheet

FY2013FY2014FY2015FY2016FY2017FY2018FY2019FY2020FY2021FY2022
Cash and equivalents00.450.2000000.260.13
Other current assets00
Total current assets00.460.2600000
Intangible assets0.020.040.04
Total assets00.490.28000000.260.13
Accounts payable0.080.160.150.160.160.210.22
Accrued liabilities0.010.010.010.020.020.040.12
Short-term debt0.6
Total current liabilities0.040.050.290.140.20.220.240.25
Total liabilities0.040.050.290.140.20.220.240.250.590.62
Paid-in capital0.034.296.154.864.864.864.864.864.864.86
Retained earnings-0.1-3.86-6.17-5-5.06-5.08-5.1-5.11-5.19-5.35
Shareholders' equity-0.040.44-0.01-0.14-0.19-0.22-0.24-0.25-0.33-0.49
Total equity-0.040.44-0.01-0.14-0.19-0.22-0.24-0.25-0.33-0.49
Total liabilities and equity00.490.28000000.260.13
Shares outstanding33178.278.478.478.478.478.478.478.478.4

Cash flow statement

FY2013FY2014FY2015FY2016FY2017FY2018FY2019FY2020FY2021FY2022
Net income-0.01-3.76-2.311.16-0.05-0.03-0.01-0.02-0.08-0.16
Depreciation and amortization0.010.02
Stock-based compensation1.221.86-1.30
Deferred income tax-0-0.38-0.17-0.07-0.02-0.01-0-0-0.02-0.04
Change in payables-0.010.080.04-0.010.080000.010.02
Cash from operations-0.02-0.93-0.25-0.2-0.02-0.04-0-0-0.01-0.07
Capital expenditures-00
Cash from investing-0.04-00
Cash from financing0.021.420.020.040.28-0.07
Net change in cash-00.26-0.13
Free cash flow-0.25-0.2
Interest paid00
Income taxes paid00

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to December 31, 2022; growth uses fiscal years. Valuation uses the share price of $0.68 on September 25, 2026.

Profitability

MetricValueHow it is calculated
Return on assets (ROA)-212.6%Net income / average total assets.

Growth

MetricValueHow it is calculated
Total assets growth, 1y-50.1%Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y527.7%Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y112.7%Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.

Balance sheet health

MetricValueHow it is calculated
Liabilities / assets688.8%Total liabilities / total assets.
Interest coverage-8.84xOperating income / interest expense.
Tangible book value-$603.4KShareholders' equity - goodwill - intangible assets.

Per share

MetricValueHow it is calculated
Book value per share-$0.01Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share-$0.01Tangible book value / shares outstanding.
Cash per share$0.00(Cash + short-term investments) / shares outstanding.

Valuation

MetricValueHow it is calculated
Market cap$53.3MShare price x shares outstanding.
Enterprise value$53.2MMarket cap + total debt - cash - short-term investments.
Earnings yield-0.4%Net income / market cap (the inverse of P/E).
Was Retrieve Medical Holdings, Inc. profitable in fiscal 2022?

No. It reported a net loss of $165.0K.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to Retrieve Medical Holdings, Inc.